检索结果 - H Dietzfelbinger

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer

    Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer 由 Florian Lordick, Sylvie Lorenzen, J. Stollfuß, Ursula Vehling‐Kaiser, Frank Kullmann, Marcus Hentrich, R. Zumschlinge, H Dietzfelbinger, Jutta Thoedtmann, Michael Hennig, T. Seroneit, Rainer Bredenkamp, Justus Duyster, C. Peschel

    出版 2005
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Cetuximab Plus Capecitabine and Irinotecan Compared With Cetuximab Plus Capecitabine and Oxaliplatin As First-Line Treatment for Patients With Metastatic Colorectal Cancer: AIO KRK-0104—A Randomized Trial of the German AIO CRC Study Group

    Cetuximab Plus Capecitabine and Irinotecan Compared With Cetuximab Plus Capecitabine and Oxaliplatin As First-Line Treatment for Patients With Metastatic Colorectal Cancer: AIO KRK... 由 Nicolas Moosmann, Ludwig Fischer von Weikersthal, Ursula Vehling‐Kaiser, Martina Stauch, Holger G. Hass, H Dietzfelbinger, Daniel Oruzio, Stefan Klein, Klaus Zellmann, Thomas Decker, Mathias Schulze, Wolfgang Abenhardt, Gerhard Puchtler, Herbert Kappauf, J. Mittermüller, C. Haberl, Andreas Schalhorn, Andreas Jung, Sebastian Stintzing, Volker Heinemann

    出版 2011
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: